A study on mice with CD200-negative melanoma tumors showed that treatment with an agonistic anti-CD200R mAb inhibited the tumor formation and metastasis in the lungs of the animals, via inhibition of myeloid cell functions (167). Here, CD200R1 is linked to neoplasm.